Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04837183 · ClinicalTrials.gov registry record
Catheter Ablation of Ventricular Arrhythmia Reduces Skin Sympathetic Activity
A clinical trial, sponsored by Mayo Clinic.
- Terminated
- Registry status
- 30
- Enrollment target
NCT04837183: Clinical Trial study, sponsored by Mayo Clinic.
NCT04837183 is a clinical trial that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04837183 was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study is being done to determine whether there is an increase in sympathetic nerve activity before the onset of ventricular arrhythmias or irregular heartbeat rhythm. In addition, this study is looking at the relationship between sympathetic nerve activity and how patients with ventricular arrhythmias respond to catheter ablation treatment.
Primary Outcome
measured in µV
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2024-01-01 |
Why NCT04837183 stopped before completion
NCT04837183 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04837183 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04837183 about?
NCT04837183 is a clinical study titled "Catheter Ablation of Ventricular Arrhythmia Reduces Skin Sympathetic Activity". This study is being done to determine whether there is an increase in sympathetic nerve activity before the onset of ventricular arrhythmias or irregular heartbeat rhythm. In addition, this study is looking at the relationship between sympathetic nerve activity and how patients with ventricular arrh...
What is the current status of trial NCT04837183?
This trial is currently terminated. The enrollment target is 30 participants. The study started on 2021-11-15. Estimated completion is 2024-01-01.
Who is sponsoring clinical trial NCT04837183?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI